PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Medical Decision Modeling Inc., Indianapolis, IN, USA.\', \'Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA.\', \'Eli Lilly and Company, 893 S. Delaware Street, Indianapolis, IN, 46225, USA. rburge@lilly.com.\', \'University of Cincinnati, Cincinnati, OH, USA. rburge@lilly.com.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1007/s12325-021-01982-6
?:hasPublicationType
?:journal
  • Advances in therapy
is ?:pmid of
?:pmid
?:pmid
  • 34807369
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.075
?:rankingScore_hIndex
  • 51
?:title
  • Cost-Effectiveness of Combination of Baricitinib and Remdesivir in Hospitalized Patients with COVID-19 in the United States: A Modelling Study.
?:type
?:year
  • 2022

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34807369>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34807369>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all